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Emerging evidence suggests that redox-active chemicals perturb pancreatic islet development. To better un
derstand potential mechanisms for this, we used zebrafish (Danio rerio) embryos to investigate roles of gluta
thione (GSH; predominant cellular redox buffer) and the transcription factor Nrf2a (Nfe2l2a; zebrafish Nrf2 coortholog) in islet morphogenesis. We delineated critical windows of susceptibility to redox disruption of β-cell
morphogenesis, interrogating embryos at 24, 48 and 72 h post fertilization (hpf) and visualized Nrf2a expression
in the pancreas using whole-mount immunohistochemistry at 96 hpf. Chemical GSH modulation at 48 hpf
induced significant islet morphology changes at 96 hpf. Pro-oxidant exposures to tert-butylhydroperoxide (77.6
μM; 10-min at 48 hpf) or tert-butylhydroquinone (1 μM; 48-56 hpf) decreased β-cell cluster area at 96 hpf.
Conversely, exposures to antioxidant N-acetylcysteine (bolsters GSH pools; 100 μM; 48-72 hpf) or sulforaphane
(activates Nrf2a; 20 μM; 48-72 hpf) significantly increased islet areas. Nrf2a was also stabilized in β-cells: 10-min
exposures to 77.6 μM tert-butylhydroperoxide significantly increased Nrf2a protein compared to control islet
cells that largely lack stabilized Nrf2a; 10-min exposures to higher (776 μM) tert-butylhydroperoxide concen
tration stabilized Nrf2a throughout the pancreas. Using biotinylated-GSH to visualize in situ protein gluta
thionylation, islet cells displayed high protein glutathionylation, indicating oxidized GSH pools. The 10-min high
(776 μM) tert-butylhydroperoxide exposure (induced Nrf2a globally) decreased global protein glutathionylation
at 96 hpf. Mutant fish expressing inactive Nrf2a were protected against tert-butylhydroperoxide-induced
abnormal islet morphology. Our data indicate that disrupted redox homeostasis and Nrf2a stabilization during
pancreatic β-cell development impact morphogenesis, with implications for disease states at later life stages. Our
work identifies a potential molecular target (Nrf2) that mediates abnormal β-cell morphology in response to
redox disruptions. Moreover, our findings imply that developmental exposure to exogenous stressors at distinct
windows of susceptibility could diminish the reserve redox capacity of β-cells, rendering them vulnerable to
later-life stresses and disease.

1. Introduction
With 100 million patients, and an annual cost of $327 billion in the
United States alone, diabetes is a pressing healthcare challenge [1].
Although diabetes is a complex multifactorial group of diseases,
pancreas dysfunction is a hallmark of all forms. The pancreas is largely
comprised of exocrine tissue that secretes enzymes to digest

biomacromolecules; the endocrine islets of Langerhans occupy approx
imately 2% of the total pancreas by volume, with pancreatic β-cells and
α-cells secreting insulin and glucagon, respectively, to regulate blood
glucose homeostasis [2]. Pancreas development in the D. rerio embryo
has been shown to be impaired by environmental conditions including
exposure to toxic chemicals, resulting in shortened pancreatic tail
lengths, reduced β-cell mass, or aberrant morphologies of islet structure

Abbreviations: BioGEE, Biotinylated Glutathione Ethyl Ester; DMSO, Dimethyl sulfoxide; Eh, Redox Potential; GSH, Glutathione; GSSG, Glutathione-disulfide; GR,
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[3–6], but the mechanisms involved are not understood. Pancreatic
β-cells in particular appear to be especially sensitive to chemicals that
cause redox disruptions, likely related to the fact that these cells rely on
reactive oxygen species (ROS) as cellular signals during differentiation
and to stimulate insulin secretion [7,8]. Although there is some di
chotomy in literature about this [9], there is a preponderance of evi
dence supporting the notion that to facilitate these functions, β-cells
possess inherently lower antioxidant capacities [7,8,10,11]. Therefore,
chemical-induced redox stress, particularly during the sensitive period
of embryonic development, could lead to disruptions in pancreatic
morphogenesis and functional consequences related to glucose homeo
stasis and pancreatic insufficiency. However, thus far our understanding
of the redox signaling of pancreatic β-cells in the embryo is limited.
Of the many redox signaling systems employed by the developing
vertebrate embryo [12], glutathione (GSH), in tandem with its oxidized
form glutathione disulfide (GSSG), provides the predominant redox
buffering system [13,14]. Disruptions of the GSH system during organ
ogenesis are known to induce adverse outcomes such as cell migration
defects, premature differentiation, apoptosis and organ agenesis [12,15,
16]. In the zebrafish (Danio rerio), GSH levels in the developing GI tract
and pancreas are especially susceptible to redox modulators when
compared to other developing organ systems [17]. Between 24 and 48 h
post fertilization (hpf), the zebrafish go through the pharyngula stage – a

period of rapid organogenesis [18]. During this time of heightened
differentiation, the GSH redox potential, defined by the ratio of reduced
GSH to oxidized GSSG, shifts from reducing at 24 hpf to oxidizing at 48
hpf [19]. The endocrine and exocrine pancreas both differentiate during
this time, with the ventral and dorsal pancreatic ducts fusing around 48
hpf (Fig. 1) [20]. Given the specific, spatiotemporal changes in GSH
levels of the developing embryo [17,19], coupled with intricate devel
opmental processes that dictate pancreatogenesis, we hypothesized that
there is differential sensitivity of the pancreas to redox disruptions at
distinct developmental timepoints.
In addition to driving the cellular redox potential, the pool of
reduced GSH serves as the substrate for glutathione-S-transferase (GST)
enzymes, which glutathionylate proteins and xenobiotics to regulate
metabolism. Protein S-glutathionylation, a reversible post-translational
modification that can activate or inactivate functional domains, pro
vides cells with a powerful control over homeostasis and can also serve
as a GSH storage system [21–23]. Induction of GST gene expression,
along with numerous other antioxidant defense genes, is largely regu
lated by the transcription factor Nuclear Factor Erythroid 2-like 2
(NFE2L2 or Nrf2) [24].
A growing body of literature has established that normal Nrf2
signaling plays important roles in embryonic development [25–28]. A
multitude of redox stressors – endogenous metabolic byproduct ROS and

Fig. 1. β-cell cluster area is impacted by redox modulation at critical windows of exposure. (A) Schematic of zebrafish pancreatic development and exposure
paradigm. [pdx1 – transcription factor in pancreatic progenitor cells; glucagon – hormone secreted by α-cells; insulin – hormone secreted by β-cells; ptf1a – tran
scription factor present in exocrine pancreas] (B) β-cell cluster area in Tg(insa:eGFP) zebrafish at 96 hpf following a short exposure to the stated redox modulating
chemical at 24 hpf then raised in clean conditions (n = 30 fish). Below, classification of aberrant islet morphologies. (C) β-cell cluster area at 96 hpf following
exposure to the stated redox modulating chemical at 48 hpf (n = 37 fish). Below, classification of aberrant islet morphologies. (D) β-cell cluster area at 96 hpf
following exposure to the stated redox modulating chemical at 72 hpf (n = 34 fish). Below, classification of aberrant islet morphologies. Different letters represent
significant differences from the control. Different letters indicate significant differences (p < 0.05) as determined by a ONE-WAY ANOVA followed by a Fisher’s LSD
Post-Hoc Test. *p < 0.05 as determined by a Chi-square test.
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exogenous xenobiotics – can deplete GSH, stabilize Nrf2 protein, and
thus activate Nrf2 nuclear translocation and target gene expression [25,
29]. Since the developing GI tract, including the pancreas, is susceptible
to GSH depletion [17], it is a sensitive target of redox stress. Moreover,
redox dysfunction is implicated as a mechanism of pancreatic β-cell
dysfunction underlying diabetes, with Nrf2 activation protecting against
the onset of diabetes [30–32]. Despite evidence for redox dysfunction
being fundamental to endocrine pancreatic disruption across multiple
model systems, the molecular pathways underlying this remain un
known. We hypothesized that glutathione depletion disrupts normal
Nrf2 signaling in embryonic pancreatic β-cells, leading to aberrant
growth and morphologies.
Here, we use gain-of-function and loss-of-function experiments to
demonstrate the sufficiency and necessity of Nrf2 disruption for aberrant
endocrine pancreatic development in the zebrafish (Danio rerio) embryo.
Zebrafish have high fecundity and their embryos demonstrate rapid
external development, serving as an excellent model for this study.
Moreover, pancreatic function and development is conserved among
zebrafish and humans, and the glutathione redox trajectory during
concordant developmental stages between the mouse and zebrafish are
also similar [25]. The zebrafish Nrf2 co-ortholog to human Nrf2 is Nrf2a
[17,27,33]. We identify distinct temporal windows of redox suscepti
bility governing pancreatic organogenesis in vivo and demonstrate the
lowered antioxidant defenses of the endocrine pancreas in situ. We also
present a novel application of biotinylated glutathione ethyl ester
(BioGEE) to probe protein glutathionylation levels in whole zebrafish
(Danio rerio) embryos in situ, allowing–for the first time–the spatial
resolution of an important post-translational modification at the whole
organism level.

approximately 20 adult female and 10 adult male fish. Embryos were
collected 1 h post fertilization, washed and screened for fertilization
status and staged according to Kimmel et al. [18]. The embryos were
dechorionated at 24 hpf and reared in borosilicate glass scintillation
vials with 1 ml 0.3x Danieau’s per embryo.
2.3. Chemical exposures
To investigate how the timing of pro-oxidant and antioxidant expo
sures impacts the development of the endocrine pancreas at either 24,
48, or 72 hpf, zebrafish eleutheroembryos (hatched and older than 72
hpf) were exposed to the following chemicals (concentrations and time
of exposure indicated in parentheses): NAC (100 μM; 24 h), SFN (20 μM;
24 h), tBOOH (77.6 μM or 776 μM; 10minutes), tBHQ (1 μM; 6 h). Water
(solvent for NAC and tBOOH) or DMSO (0.01%; solvent for SFN and
tBHQ). Vehicle control exposures were run concurrently. The exposure
durations were selected based on the known modes of action of these
chemicals. Embryos were exposed to SFN and tBHQ for different time
periods based on prior studies demonstrating these compounds required
different amounts of time to induce Nrf2-mediated transcriptional
response in zebrafish embryos [37,38]. All eleutheroembryos were
manually dechorionated using watchmakers forceps at 24 hpf.
Following exposures, fish were thoroughly washed and maintained in
0.3x Danieaus (http://cshprotocols.cshlp.org/content/2011/7/pdb.rec
12467) for microscopy or immunohistochemistry at 96 hpf.
2.4. Immunohistochemistry
Embryos were fixed in 4% PFA in PBS for 24 h at 4 ◦ C at a ratio of 15
embryos/ml PFA. Embryos were rinsed in 0.1% PBS-Tween-20 (PBST),
and stored in 100% methanol at – 20 ◦ C overnight. Samples were
rehydrated using methanol-PBST gradients. Heat antigen retrieval was
done by heating the rehydrated samples at 70 ◦ C for 20 min. Immedi
ately following heat retrieval, samples were permeabilized using icecold acetone for 8 min. Samples were blocked using 5% Sheep’s serum
in PBST for 2 h at room temperature, followed by the previously char
acterized anti-Nrf2a antibody (1:1000 in block) for 48 h at 4 ◦ C [6].
Samples were placed in Alexa-594 tagged anti-rabbit antibody (1:5000
in block) overnight. Samples were washed with PBST and stored in
Vectashield containing DAPI at 4 ◦ C until imaging. A subset of embryos
were run through the entire immunohistochemistry (IHC) procedure,
without using any primary antibody as a control for non-specific binding
of secondary antibody. The most robust response for Nrf2a, seen with a
10-min exposure to 77.6 μM tBOOH, was included as a positive control
in every IHC procedure experiment.
For BioGEE samples, embryos were exposed to 100 μM BioGEE for 2
h prior to fixation. Following fixation, all steps were identical until
blocking. Post-blocking, samples were placed in AlexaFluor 594 tagged
Streptavidin (1:5000) for 1 h at room temperature. Samples were then
washed with PBST and stored in Vectashield containing DAPI at 4 ◦ C
until imaging. A subset of embryos were run through the entire immu
nohistochemistry procedure, without exposing them to BioGEE as a
control for non-specific binding of AlexaFluor 594 tagged Streptavidin.

2. Materials and methods
2.1. Chemicals and reagents
Paraformaldehyde (PFA; Catalog # AAJ19943K2), Phosphate Buff
ered Saline (PBS; Catalog #AAJ75889AE), Methanol (Catalog #A4124), Tween-20 (Catalog #BP337-100), and Dimethyl Sulfoxide (DMSO;
Catalog #BP231-1) were purchased from Fisher Scientific (Pittsburgh,
PA, USA). Tert-Butyl hydroperoxide (tBOOH; Catalog #A13926AP) and
N-acetyl-L-cysteine (NAC; Catalog #A1540914) were purchased from
Alfa Aesar (Ward Hill, MA, USA). Tert-butyl hydroquinone (tBHQ;
Catalog #AC150820050) was purchased from Acros Organics (NJ,
USA). DL-Sulforaphane (SFN; Catalog #S4441) was purchased from
Millipore-Sigma (Burlington, MA, USA). Vectashield Antifade Mounting
Medium with DAPI (Catalog #H-1200) was purchased from Vector
Laboratories (Burlingame, CA, USA). Chicken Anti-Rabbit IgG Alexa
Fluor 594 (Catalog # A-21442), AlexaFluor 594 tagged Streptavidin
(Catalog #S32356) and Biotinylated Glutathione Ethyl Ester (BioGEE;
Catalog #G36000) were purchased from Invitrogen (Carlsbad, CA,
USA).
2.2. Fish husbandry and embryo sampling
Tg(insa:eGFP) [34] and Tg(gcga:eGFP) [35] transgenic zebrafish on
wild type (AB) background were used for in vivo observation of the
β-cells and α -cells, respectively. Homozygous wild type (nrf2a+/+) and
nrf2afh318/fh318 [36] crossed with Tg(insa:eGFP) zebrafish embryos on an
AB strain background were used to investigate the Nrf2 pathway in the
developing β-cells. All breeding adults were maintained on an auto
mated Aquaneering (San Diego, CA, USA) system in accordance with the
Guide for the Care and the Use of Laboratory Animals of the National
Institutes of Health and with approval from the University of Massa
chusetts Amherst Institutional Animal Care and Use Committee (Animal
Welfare Assurance Number A3551-01). The fish were housed at 28.5 ◦ C
on a 14 h light, 10 h dark cycle, and fed GEMMA Micro 300 (Skretting,
Westbrook, ME, USA) twice daily. Large breeding tanks were setup with

2.5. Microscopy
Larvae were imaged at 96 hpf to observe the effects of exposure on
the development of the primary islet, using an upright Olympus com
pound fluorescence microscope equipped with a Zeiss Axiocam 503
camera and Zen analysis software (Zeiss, USA). Fish were briefly anes
thetized in 0.3x Danieaus containing MS-222 and staged laterally in 3%
methylcellulose to optimize visualization of the endocrine islet. Images
were captured using monochrome and GFP fluorescence filters at 2×,
5×, and 10× magnification to assess gross morphology and islet struc
ture. Images were blinded, then analyzed using Zen (Zeiss) analysis
software. Islet area was determined by tracing the perimeter of the cell
3
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cluster on the 10× GFP images, and the area was calculated by the
software. Islet morphology was also assessed to quantify the frequency
of islet variants such as hypomorphic, fragmented, stunted, hollow is
lets, or ectopic endocrine cells [39].
Larvae with immunohistochemistry for Nrf2a or BioGEE were
imaged using a Nikon A1 Spectral Detector Confocal microscope
equipped with 405 nm, 488 nm, 561 nm and 640 nm laser lines. Z-stacks
were taken through the entire pancreas, using a 40× objective, 0.3 pixels
equated 1 μm when imaging the whole pancreas, scale bars represent 20
μm. Sequence scanning was used to eliminate cross-channel fluores
cence overlap. Images presented here are collapsed max-intensity pro
jections, flipped horizontally to reflect the biological orientation of the
pancreas. Structure outlines were drawn using the DAPI channel images;
higher magnification confocal images cannot be obtained due to the
physical limitations of the objective working distance that wholeorganism mounts presented. Images were graded in a blinded manner
for expression patterns based on OECD guidelines [40,41].

morphologies (Fig. 1). The antioxidant NAC and SFN induced a 20% and
25% increase in β-cell area, respectively (p < 0.05). The two prooxidants each produced a ~25% decrease in β-cell area when
measured at 96 hpf, along with ~1000% increase in the incidence of
variant islet morphologies (Fig. 1; p < 0.05). tBOOH and tBHQ at 48 hpf
were the only treatments where the α-cells showed a response; there was
a 5% reduction in α-cell area upon these exposures (Supp. Fig. S1). This
reduction in α-cell area likely reflects the 25% reduction in β-cell area, as
β-cells form the core of the spherical islet.
Redox modulation at 72 hpf produced changes in β-cell cluster area
for three of the four chemicals, with the antioxidant SFN resulting in a
significant increase, and the two pro-oxidants tBHQ and tBOOH result
ing in a decrease in area. Each of these chemical exposures also resulted
significant increases in aberrant islet morphology, with the two Nrf2
activating chemicals (SFN and tBHQ) resulting in an increase in stunted
β-cell clusters. (Fig. 1).

2.6. Statistics

3.2. Endocrine pancreas has low endogenous antioxidant defenses during
development

To assess statistical significance of islet morphology variants re
ported in Fig. 1, we used Analysis of Variance (One-Way ANOVA) tests,
followed by a Fishers Least Significant Differences (LSD) Post-Hoc Test.
In Fig. 6, a One-Way ANOVA followed by a Tukey-Kramer post-hoc was
used to assess tBOOH induced morphology changes. All statistical tests
were performed in JMP Pro 14. All experiments were repeated for 5-7
biological replicates (total n > 30 fish). To assess statistical signifi
cance of immunohistochemistry expression patterns, χ2 tests were car
ried out using Excel, statistical significance was set to a p-value of 0.05.
All experiments were repeated for 4-5 biological replicates (total n ≥ 12
fish); meeting or exceeding OECD guidelines [40,41].

We characterized antioxidant defense levels of the endocrine
pancreas using anti-Nrf2a antibodies and BioGEE; the latter is an indi
cator of protein-GSH mixed disulfides formed during oxidative stress
[44]. None of the fish had Nrf2a expression in the islet (p < 0.05), while
100% had detectable protein glutathionylation (p < 0.05) (Fig. 2). In
contrast, Nrf2a was robustly detected in the exocrine pancreas, indi
cating the effectiveness of the Nrf2a antibody and IHC procedure.
Moreover, the robust expression of Nrf2a protein in the exocrine pan
creata in all embryos suggests that the decreased Nrf2a levels in the
endocrine islet are indicative of lower endogenous antioxidant defenses
in these cells.

3. Results
3.1. Endocrine pancreatic organogenesis is governed by distinct
spatiotemporal windows of redox susceptibility

3.3. Peroxide-induced GSH depletion activates Nrf2a and impacts protein
glutathionylation in the pancreas

To delineate critical windows of endocrine pancreatic susceptibility
to redox disruption, we exposed zebrafish embryos to small molecules
with either pro-oxidant or antioxidant activities for a brief period
starting at either 24, 48 or 72 hpf, then raised the embryos in clean
conditions and imaged the primary islet at 96 hpf. The redox modulators
used were N-acetylcysteine (NAC) – which bolsters cellular GSH pools,
tert-butylhydroperoxide (tBOOH) – a ROS generator that depletes
cellular GSH, and sulforaphane (SFN) and tert-butylhydroquinone
(tBHQ) – both Nrf2a activators [42,43]. Concentrations were selected to
be below those causing lethality, overt morphological deformities, or
impacts on growth, but sufficient to affect either the glutathione redox
potential or Nrf2 activation.
The 24 hpf exposure window was most sensitive to the two prooxidants, tBHQ and tBOOH, which both resulted in significant de
creases in the β-cell cluster area at 96 hpf and also increased occurrence
of aberrant β-cell arrangement morphology. Exposure to tBOOH (77.6
μM) decreased β-cell cluster area by 18% (p < 0.05), and tBHQ exposure
(1 μM) decreased β-cell area by 16% (p < 0.05). β-cell arrangements in
the islet were significantly impacted by three of the four chemicals;
tBHQ exposure increased occurrence of atypical arrangements of β-cells
by 900% (p < 0.05) (Fig. 1) including fragmented islets and ectopic
β-cells as previously described [5], and tBOOH exposure increased
occurrence by 400%. Exposure to NAC or SFN at 24 hpf did not induce
significant changes in either β-cell (Fig. 1) or α-cell areas (Fig. S1) when
analyzed at 96 hpf, although exposure to NAC resulted in a significant
increase in abnormal islet morphology (Fig. 1).
The islet was most sensitive to redox modulation at 48 hpf, with all
four chemical exposures inducing significant changes in β-cell area and
three of the four chemicals producing significant incidences of aberrant

Given the heightened sensitivity of the endocrine pancreas to tBOOH
exposure at 48 hpf, we investigated Nrf2a dynamics and protein gluta
thionylation in response to tBOOH treatment. Exposure to tBOOH (77.6
μM) at 48 hpf resulted in 100% of the larvae having stabilized Nrf2a in
pancreatic β-cells at 96 hpf (p < 0.05; Fig. 3; Table 1) and protein glu
tathionylation in the endocrine and exocrine pancreata (p < 0.05; Fig. 3;
Table 1). In this study, we conservatively refer to visible Nrf2a protein as
being stabilized, i.e. bound to Keap1 or not degraded by proteasome
since we have not measured actual Nrf2a protein expression levels, and,
the exact mechanics of the Nrf2a pathway remain a subject of debate in
literature [24].
Exposure to a higher tBOOH concentration (776 μM) at 48 hpf
resulted in the entire pancreas showing elevated levels of Nrf2a,
accompanied by decreased global protein glutathionylation (p < 0.05;
Fig. 3; Table 1), indicating Nrf2a stabilization ameliorates oxidative
stress. Both 77.6 and 776 μM tBOOH are sublethal concentrations with
no overt toxic or growth effects in the zebrafish embryo [17,26]. A 24-h
pretreatment with 100 μM NAC, which bolsters cellular GSH pools,
prevented the altered Nrf2a expression effects seen with both 77.6 μM
and 776 μM tBOOH in 100% of the fish, indicating that GSH can protect
against Nrf2a stabilization in pancreatic β-cells (Fig. 3; Table 1). In Nrf2a
mutant (m/m) fish, which carry a mutation in the DNA-binding domain
of Nrf2a, allowing for Nrf2a expression but hampering Nrf2a tran
scriptional activity [36], 77.6 μM tBOOH did not stabilize Nrf2a (Fig. 3;
Table 1), suggesting that the stabilization of Nrf2a to mild redox chal
lenges involves its own de novo upregulation. This is in contrast to the
finding with the 10-fold higher, 776 μM tBOOH treatment, which sta
bilized Nrf2a in the mutant fish in a pattern similar to that seen in the
Nrf2a wildtype fish (Fig. 3; Table 1).
4
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Fig. 2. Endocrine pancreas has lower antioxidant defenses. (A) Schematic of all the Nrf2a redox modulators used in this study. (B) Nrf2a expression in pancreatic
head and neck of 96 hpf zebrafish embryos (n = 23 fish). (C) Protein glutathionylation in pancreata of 96 hpf zebrafish embryos (n = 13 fish). Solid lines denote
exocrine pancreas, dashed lines denote endocrine pancreas.

3.4. SFN and tBHQ impact Nrf2a expression protein levels and protein
glutathionylation

3.5. Nrf2a m/m fish are protected against aberrant islet morphologies
To determine the contribution of Nrf2a in the development of
aberrant islet morphologies, we exposed Nrf2a wt/wt and Nrf2a m/m
embryos to tBOOH (77.6 μM) at 48 hpf and measured fish length and
β-cell area. Incidence of hypomorphic islets was calculated as previously
described [39]; briefly, the 10th percentile of the control measurements
was calculated, and the numbers of individuals in each treatment group
that fell below were considered hypomorphic; this is presented as the
percent of the samples that met that criteria.
Fish length was unaltered, indicating the observed changes were
β-cell specific, as opposed to overall decreased growth (Fig. 6). We found

Upon exposure to the Nrf2a activators tBHQ and SFN, 100% of the
Nrf2a wt/wt embryos demonstrated a near total absence of Nrf2a
expression in both the endocrine and exocrine pancreas (p < 0.05;
Figs. 4 and 5; Tables 2 and 3). Protein glutathionylation levels were not
altered by treatments (p < 0.05; Figs. 4 and 5; Tables 2 and 3). In
contrast, Nrf2a m/m fish showed increased stabilization of Nrf2a (p <
0.05; Figs. 4 and 5 Tables 2 and 3).
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Fig. 3. Pancreatic Nrf2a expression and protein glutathionylation patterns in response to tBOOH exposure. (A) Exposure paradigm. (B) Potential mechanism
for tBOOH-mediated changes in Nrf2a and protein glutathionylation. (C) Nrf2a and protein glutathionylation patterns in pancreata of fish exposed to stated
treatments. Solid lines denote exocrine pancreas, dashed lines denote endocrine pancreas; representative images from 10 to 14 fish. Scale bars represent 20 μm.
Grayscale split channel images of the Nrf2a immunohistochemistry are provided in Supplementary Fig. 2, and BioGEE immunohistochemistry in Supplemen
tary Fig. 3.

31]. Interrupting these pathways can induce abnormal pancreatic
morphologies, potentially predisposing individuals to adverse health
outcomes [3–6]. In this study, we characterize, for the first time, the
glutathione redox conditions and Nrf2a protein levels in the developing
endocrine pancreas. We demonstrate that exposure to redox-active xe
nobiotics at specific developmental timepoints can cause prolonged
disruptions in Nrf2 protein expression in pancreatic β-cells. Our findings
are indicative of a peroxide-mediated decrease in the reserve redox ca
pacity of β-cells, with potential implications for β-cell function later in
life.
We found distinct windows of pancreatic β-cell susceptibility to
redox modulation, with embryos aged 48 hpf being most susceptible to
abnormal endocrine pancreas morphologies. In the zebrafish embryo,
the redox potential is oxidizing and GSH levels in the developing gut
decrease at 48 hpf, providing a possible explanation for the significance
of this timepoint (Fig. 1) [17,19]. Of all the parameters measured, β-cell
cluster area is most impacted, whereas fish length is not affected and
α-cell cluster area decreases only slightly, indicating the inherent sus
ceptibility of β-cells to redox disruptions (Fig. 1; Fig. 6; Supp. Fig. 1). The
redox sensitivity of pancreatic β-cells is further characterized by unde
tectable levels of Nrf2a and the higher levels of protein glutathionylation
in the pancreatic islet, as compared to the exocrine pancreas (Fig. 2).
Elevated glutathionylation is a marker of oxidative stress, and an
oxidizing GSH redox potential [21]. Oxidizing redox potentials equate to
lower levels of reduced GSH, and consequently, lower buffering capacity
against oxidative insults.
The pro-oxidant tBOOH induced the most dramatic changes in β-cell
morphology, with a short 10-min treatment at 48 hpf inducing changes
sustained two days later at 96 hpf (Fig. 1). Previously, we showed that a
similar 10-min tBOOH treatment at 48 hpf depletes 50% of the GSH pool
in the zebrafish embryo, and the GSH pools within the embryo start to
recover about 1.5 h post treatment [17]. We found that Nrf2a stabili
zation increases post tBOOH treatment, and two days later at 96 hpf it is
still stabilized specifically in β-cells (Supp Fig. 1; Fig. 3; Table 1).
It should be noted that exposure to tBHQ and sulforaphane induced
opposite changes in β-cell morphology, with sulforaphane inducing an

Table 1
Nrf2a and BioGEE status of islets treated with tBOOH. *p < 0.05 as determined
by a Chi-Square test.
Genotype

Treatment

Nrf2a Positive
Islets (%)

BioGEE Positive
Islets (%)

Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a m/m
Nrf2a m/m
Nrf2a m/m

Untreated Controls

0 (n = 12 fish)

100 (n = 12 fish)

77.6 μM tBOOH

100* (n = 13 fish)

0* (n = 10 fish)

776 μM tBOOH

100* (n = 13 fish)

0* (n = 13 fish)

100 μM NAC

0 (n = 12 fish)

–

77.6 μM tBOOH + 100
μM NAC
776 μM tBOOH + 100
μM NAC

0 (n = 12 fish)

–

0 (n = 12 fish)

–

0 (n = 12 fish)
0 (n = 14 fish)
100 (n = 12 fish)

100 (n = 12 fish)
100 (n = 10 fish)
100 (n = 13 fish)

Untreated Controls
77.6 μM tBOOH
776 μM tBOOH

that wildtype embryos were more susceptible to decreases in both β-cell
area and the incidence of hypomorphic islets (Fig. 6). Nrf2a wt/wt
embryos exposed to 77.6 μM tBOOH showed a 13% reduction in β-cell
area (p < 0.05) and a 300% increase in hypomorphic islets; embryos
exposed to 776 μM showed an 18% reduction in β-cell area (p < 0.05)
and a 100% increase in hypomorphic islets. Nrf2a m/m fish, on the other
hand, showed no effect of tBOOH at a dose of 77.6 μM on either of these
parameters (Fig. 6). Although at the 10-fold higher 776 μM dose of
tBOOH the Nrf2a m/m embryos did show a decrease pf 4% (p < 0.05) in
islet area, this was much smaller than the 18% decrease observed in
wildtype embryos. This demonstrates that Nrf2a plays a role in tBOOHmediated changes in β-cell morphology.
4. Discussion
Pancreatic development utilizes a dynamic network of redoxsensitive signaling pathways that dictate organ morphogenesis [30,
6
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Fig. 4. Pancreatic Nrf2a expression and protein glutathionylation patterns in response to tBHQ exposure in zebrafish embryos. (A) Nrf2a protein and (B)
protein glutathionylation patterns in pancreata of fish exposed to 1 μM tBHQ from 48 to 54 hpf. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas; representative images from 11 to 14 fish. Scale bars represent 20 μm. Grayscale split channel images of the Nrf2a immunohistochemistry are provided in
Supplementary Fig. 4, and BioGEE immunohistochemistry in Supplementary Fig. 5.

Fig. 5. Pancreatic Nrf2a expression and protein glutathionylation patterns in response to SFN exposure in zebrafish embryos. (A) Nrf2a protein and (B)
protein glutathionylation patterns in pancreata of fish exposed to 20 μM SFN from 24 to 48 hpf. Solid lines denote exocrine pancreas, dashed lines denote endocrine
pancreas; representative images from 11 to 13 fish. Scale bars represent 20 μm. Grayscale split channel images of the Nrf2a immunohistochemistry are provided in
Supplementary Fig. 4, and BioGEE immunohistochemistry in Supplementary Fig. 5.

increase in β-cell mass and tBHQ inducing a decrease in β-cell mass. This
may be attributed to the different modes of action of the two chemicals.
While SFN is considered a antioxidant, its function as such is mediated
through upregulation of innate antioxidant defense mechanisms via
activation of Nrf2 [45]. Thus, SFN protects against oxidative damage by
arming the cell with its own defense systems. On the other hand, tBHQ
has been classified as a potent Nrf2 activator through oxidative modi
fication of Keap1 [46]. Thus, tBHQ acts as a weak pro-oxidant, in
addition to activating Nrf2, similar to tBOOH.
The exocrine pancreata of fish exposed to 77.6 μM tBOOH lack the
increased levels of Nrf2a protein whereas exposure to 776 μM tBOOH, a
10-fold higher dose, results in global Nrf2a protein expression (Fig. 3;
Table 1). Additionally, a 100 μM NAC pretreatment, which bolsters
cellular GSH, prevents the increase in Nrf2a expression at both doses of
tBOOH. Thus, artificially increasing GSH levels in β-cells increases the
inherent buffering capacity, requiring greater GSH depletion for prooxidant-mediated Nrf2a stabilization.
Exposing Nrf2a m/m embryos, which carry a mutation in the DNAbinding domain of Nrf2a, to 77.6 μM tBOOH does not elicit an in
crease in Nrf2a protein in the islet. In contrast, the 10-fold higher 776
μM tBOOH exposure does induce global Nrf2a protein expression in the
pancreas (Fig. 3; Table 1). This suggests Nrf2a may self-regulate its de
novo upregulation and subsequent stabilization in response to mild
tBOOH mediated GSH depletion until a threshold is reached. However,
once GSH drops below this internal setpoint, Nrf2a is triggered; in the

zebrafish, this could potentially be activated by Nrf2b, a co-ortholog of
Nrf2a [26,33] or perhaps other members of the Nrf family. Nrf2a protein
increases are accompanied by decreased protein glutathionylation,
dependent upon the magnitude of redox stress (Fig. 3; Table 1). This is
readily apparent in embryos exposed to 776 μM tBOOH, where the
global increase in Nrf2a expression led to a global decrease in protein
glutathionylation levels (Fig. 3; Table 1).
Another possibility for the decreased protein glutathionylation levels
seen following 776 μM tBOOH exposure is that the labile GSH pools are
depleted in these embryos to combat the higher levels of ROS. Thus,
these embryos might display increased levels of protein gluta
thionylation later in time, as the GSH pools recover.
One potential explanation for the sustained high levels of Nrf2a seen
in the β-cells in response to tBOOH exposure could be the mechanism by
which tBOOH is detoxified. tBOOH serves as a substrate for glutathione
peroxidase 1 and glutathione peroxidase 4 [47]. In pancreatic β-cells
Gpx expression levels are very low, and slower tBOOH catalysis likely
leads to sustained secondary oxidative stress [10]. Gpx4 overexpression
in β-cells has been demonstrated to reduce the generation of lipid hy
droperoxides (including tBOOH), and reverse diabetic phenotypes [48,
49]. Gpx expression can also be triggered by Nrf2a, with Gpx reporters
being activated by the canonical Nrf2a activators tBHQ and SFN [50].
Thus, the elevated Nrf2a expression is likely a response by the embryo to
try and return to homeostatic conditions by neutralizing tBOOH. In the
exocrine pancreas, the innate antioxidant defenses coupled with Nrf2a
7
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Fig. 6. Nrf2a is essential for redox dependent
disruption of β-cell morphology. Nrf2a wt/wt or
Nrf2a m/m fish were exposed to water (n = 70 fish),
77.6 μM tBOOH (n = 32 fish) or 776 μM tBOOH (n
= 35 fish) for 10 min at 48 hpf and their length (A),
β-cell cluster area (B) and incidence of hypomorphic
islets (cutoff represented by dashed line) (C) were
measured at 96 hpf. Different letters indicate
significantly different means across indicated group.
p < 0.05 compared to respective control as deter
mined by a 1-way ANOVA followed by a TukeyKramer post-hoc.

are sufficient to neutralize tBOOH; in the endocrine pancreas the lower
antioxidant defenses delay this recovery, leading to elevated Nrf2a
expression levels two days later.
Interestingly, tBHQ and SFN, both activators of Nrf2a caused a near
total absence of Nrf2a expression in both the endocrine and exocrine
pancreas of exposed Nrf2a wt/wt fish (Figs. 4 and 5). Despite the
absence of Nrf2a expression, significantly elevated levels of protein
glutathionylation were observed following tBHQ and SFN treatment.
These results are congruent with our findings with 776 μM tBOOH in

Nrf2a wt/wt fish, where increased Nrf2a was accompanied by decreased
protein glutathionylation. In Nrf2a m/m fish, we saw high levels of
Nrf2a expression upon tBHQ and SFN exposure, but this did not impact
protein glutathionylation levels, which remained high. Thus, Nrf2a ac
tivity appears necessary for changes in protein glutathionylation in the
pancreas.
Nrf2a mutant embryos showed increased Nrf2a stabilization levels
upon tBHQ and SFN exposures (Figs. 4 and 5). This implies that the lack
of Nrf2a expression seen in Nrf2a wildtype embryos upon these
8
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characterized mechanism of transcriptional and functional regulation
of proteins [22]. Within pancreatic β-cells, reversible glutathionylation
of the inner mitochondrial membrane protein, Uncoupling Protein – 2, is
necessary for glucose stimulated insulin secretion, and consequently,
β-cell function [52]. Moreover glutathionylation of Kelch Like ECH
Associated Protein 1 (Keap1), the cytosolic repressor of Nrf2, increases
cellular Nrf2 protein levels [53]. This glutathionylation is catalyzed by
GSTπ, a downstream target of Nrf2a; previously, we have shown altered
GSTπ activity in the developing zebrafish pancreas upon exposure to
multiple redox stressors including tBOOH [17]. GSTπ also silences the
JNK signaling pathway via protein glutathionylation [54]. This is
notable in the context of pancreatic β-cells, as the pancreatic and
duodenal homeobox-1 (PDX1) transcription factor is known to be
regulated by JNK signaling. PDX1 is essential for the differentiation of
pancreatic β-cells, and, controls the expression of insulin [20,55].
Oxidative stress induced disruption of PDX1 signaling, a hallmark of
diabetes, can be rescued by restoration of normal JNK signaling [56].
Nrf2a protein expression is highly consistent in the developing
zebrafish pancreas, with 23 embryos displaying similar expression pat
terns (Fig. 2). We find that multiple redox modulators induce sustained
disruptions to these expression patterns (Figs. 3–5). This sustained de
parture from normal signaling could have severe ramifications for the
development of disease states, with altered baseline Nrf2a levels
rendering pancreatic β-cells vulnerable to subsequent redox active
xenobiotic exposures. Concordant with our results, in healthy human
pancreatic β-cells Nrf2 is largely absent; Nrf2 activation is indicated as a
coping mechanism for stressed β-cells, accompanied by reduced insulin
secreting capacity [57,58]. Thus, while activation of Nrf2 in β-cells can
promote cell survival, these cells are not as effective in regulating blood
glucose levels.
The transcriptomic profiles of β-cells are well-conserved in zebrafish
and humans [59]. Within humans, Nrf2 expression is known to be very
low in pancreatic β-cells. Gclc, the catalytic subunit of the enzyme that
catalyzes GSH synthesis is also expressed at very low levels. Moreover,
Gstπ, a gene transcriptionally regulated by Nrf2 is expressed at 2.5 fold
lower levels in β-cells than in exocrine pancreatic cells [60].
A wide array of xenobiotics and pharmaceuticals impact develop
mental GSH profiles, and, consequently Nrf2. Nrf2 is highly pleiotropic,
with many functions in biological processes like inflammation, lipid and
xenobiotic metabolism and DNA repair, in addition to the central role it
plays in cancer [27,28,61,62]. While Nrf2 is widely studied in the
context of its protective activities, there is also a dark side including
upregulation in cancer cells, where it can confer cytoprotection from
chemotherapeutics, and in mutagenesis where genes upregulated by
Nrf2 can lead to increased bioactivation of pro-carcinogens [62–64].
This underscores the need to better characterize the functions of Nrf2
during development. This study, to the best of our knowledge, is the first
to interrogate Nrf2a expression patterns in the endocrine pancreas in situ
during embryogenesis. During the course of this study, we discovered
that treatment with redox modulators induced sustained changes in
Nrf2a protein levels.
To maintain data fidelity, all images were acquired under the same
microscope settings. An unfortunate consequence of this was the
inability to quantitatively analyze the images due to certain treatment
conditions (e.g. 776 μM tBOOH) saturating the fluorescence detector.
We acknowledge that this is a limitation of the current study. However,
the study is informative about endogenous and modulated redox pat
terns in the developing pancreas. Furthermore, it can be used to inform
future studies where changes in Nrf2a protein and protein gluta
thionylation levels can be quantified.
Disruptions in developmental Nrf2a signaling that manifest as subtle
changes, as demonstrated in this study, are easily overlooked until dis
ease occurs. These subtle changes in pancreatic morphology could pre
dispose an individual to develop metabolic disease later in life. Indeed,
in multiple epidemiological studies in humans, toxicant exposure has
been closely associated with increased rates of metabolic disorders and

Table 2
Nrf2a and BioGEE status of islets treated with tBHQ. *p < 0.05 as determined by
a Chi-Square test.
Genotype

Treatment

Nrf2a Positive Islets
(%)

BioGEE Positive Islets
(%)

Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a m/m

0.01%
DMSO
1 μM tBHQ

0 (n = 12 fish)

100 (n = 11 fish)

0 (n = 13 fish)

100 (n = 14 fish)

0.01%
DMSO
1 μM tBHQ

0 (n = 12 fish)

100 (n = 12 fish)

100* (n = 12 fish)

100 (n = 13 fish)

Nrf2a m/m

Table 3
Nrf2a and BioGEE status of islets treated with SFN. *p < 0.05 as determined by a
Chi-Square test.
Genotype

Treatment

Nrf2a Positive Islets
(%)

BioGEE Positive Islets
(%)

Nrf2a wt/
wt
Nrf2a wt/
wt
Nrf2a m/m

0.01%
DMSO
20 μM SFN

0 (n = 12 fish)

100 (n = 11 fish)

0 (n = 13 fish)

100 (n = 11 fish)

0.01%
DMSO
20 μM SFN

0 (n = 12 fish)

100 (n = 12 fish)

100* (n = 12 fish)

100 (n = 12 fish)

Nrf2a m/m

exposures is mediated by Nrf2a or a downstream target of Nrf2a. In the
zebrafish embryo, exposure to a ten-fold higher dose of tBHQ (10 μM)
than the dose we used (1 μM), is insufficient to induce Nrf2a expression
in 48 hpf, 72 hpf and 96 hpf embryos [38]. Genes downstream of Nrf2a,
especially those involved in GSH synthesis are induced by 300%, but
Nrf2a itself is not induced [38]. Among the highest induced genes are
the heat shock proteins Hsp70 and Hsp90, the induction of Hsp70 in
response to tBHQ mediated Nrf2a activation has been confirmed in
multiple studies [26,33,38]. Both these proteins help stabilize protein
folding, by either delaying completion of protein folding, or, acceler
ating proteasomal degradation of misfolded proteins [51]. Thus,
changes in the total protein levels of Nrf2a might be masked by over
expression of Hsp70 and Hsp90. Given the increase in protein gluta
thionylation, it is apparent that tBHQ and SFN induce high levels of
oxidative stress, arising at least in part due to decreased Nrf2a levels
(Figs. 4 and 5; Tables 2 and 3). It is possible that wildtype embryos
recover Nrf2a levels sometime post 96 hpf; this merits further
investigation.
Nrf2a mutant embryos were protected against the abnormal islet
morphologies seen with 77.6 μM tBOOH, whereas wild-type embryos
expressing functional Nrf2a showed a 13% decrease in islet area and a
300% increase in incidence of hypomorphic islets. Although the 10-fold
higher 776 μM tBOOH exposure, induced decreases in both wild type
and mutant fish, the decrease in islet area was significantly greater in
Nrf2a wt/wt fish (18%) as compared to Nrf2a m/m fish (4%). Fish
length was unaffected, indicating no overt toxicity due to exposures
(Fig. 6). Both Nrf2a wt/wt and Nrf2a m/m embryos exposed to 77.6 μM
tBOOH presented a slightly greater number of hypomorphic islets than
embryos exposed to 776 μM tBOOH (Fig. 6). This may be due to the large
increase in Nrf2a stabilization observed only in the islet following
exposure to 77.6 μM tBOOH (Fig. 3; Table 1).
Given that Nrf2a mutant embryos are protected against altered Nrf2a
expression patterns in response to redox stresses (Figs. 3–5), altered
redox signaling during development appears to be important for dis
rupted endocrine pancreatogenesis. A possible mechanism for this is
Nrf2a-mediated changes in glutathionylation, supported by the fact that
776 μM tBOOH triggered Nrf2a expression in Nrf2a m/m embryos but
did not decrease protein glutathionylation as seen in Nrf2a wt/wt em
bryos (Fig. 3; Table 1). Differential glutathionylation is crucial from a
developmental perspective, as protein glutathionylation is a well9
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diabetes [65]. Moreover, we find critical windows of susceptibility to
redox disruptions for the endocrine pancreas. This could have implica
tions for identifying sensitive windows of pancreas development in
humans.
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